{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:57:56Z","timestamp":1768715876936,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005217","name":"National Center for Injury Prevention and Control","doi-asserted-by":"crossref","award":["5U01CE002162-02"],"award-info":[{"award-number":["5U01CE002162-02"]}],"id":[{"id":"10.13039\/100005217","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012755","name":"Kate B. Reynolds Charitable Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012755","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005561","name":"North Carolina Department of Health and Human Services","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005561","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inj. Epidemiol."],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40621-018-0179-2","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T12:16:00Z","timestamp":1547468160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Associations between implementation of Project Lazarus and opioid analgesic dispensing and buprenorphine utilization in North Carolina, 2009\u20132014"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-2889","authenticated-orcid":false,"given":"Apostolos A.","family":"Alexandridis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabarun","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka D.","family":"McCort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Ringwalt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne D.","family":"Rosamond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Chelminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen W.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,21]]},"reference":[{"issue":"Suppl 2","key":"179_CR1","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1111\/j.1526-4637.2011.01128.x","volume":"12","author":"S Albert","year":"2011","unstructured":"Albert S, Brason FW 2nd, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011;12(Suppl 2):S77\u201385.","journal-title":"Pain Med"},{"key":"179_CR2","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.drugalcdep.2016.08.031","volume":"171","author":"AA Alexandridis","year":"2017","unstructured":"Alexandridis AA, Dasgupta N, Ringwalt C, Sanford C, McCort A. Effect of local health department leadership on community overdose prevention coalitions. Drug & Alcohol Depend. 2017;171:e5\u20136.","journal-title":"Drug & Alcohol Depend"},{"key":"179_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/injuryprev-2017-042396","volume":"24","author":"AA Alexandridis","year":"2018","unstructured":"Alexandridis AA, McCort A, Ringwalt CL, Sachdeva N, Sanford C, Marshall SW, et al. A statewide evaluation of seven strategies to reduce opioid overdose in North Carolina. Inj Prev. 2018;24:48\u201354.","journal-title":"Inj Prev"},{"issue":"3","key":"179_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/ADM.0b013e3181ba895d","volume":"4","author":"RD Blondell","year":"2010","unstructured":"Blondell RD, Ashrafioun L, Dambra CM, Foschio EM, Zielinski AL, Salcedo DM. A clinical trial comparing tapering doses of buprenorphine with steady doses for chronic pain and co-existent opioid addiction. J Addict Med. 2010;4(3):140\u20136.","journal-title":"J Addict Med"},{"issue":"1","key":"179_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1108\/IJPH-08-2016-0039","volume":"13","author":"L Brinkley-Rubinstein","year":"2017","unstructured":"Brinkley-Rubinstein L, Cloud DH, Davis C, Zaller N, Delany-Brumsey A, Pope L, et al. Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings. Int J Prison Health. 2017;13(1):25\u201331.","journal-title":"Int J Prison Health"},{"issue":"Supplement_4","key":"179_CR6","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1086\/508184","volume":"43","author":"MP Carrieri","year":"2006","unstructured":"Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Buprenorphine use: the international experience. Clin Infect Dis. 2006;43(Supplement_4):S197\u2013215.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"179_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/pm\/pnw129","volume":"18","author":"MS Cepeda","year":"2017","unstructured":"Cepeda MS, Coplan PM, Kopper NW, Maziere J-Y, Wedin GP, Wallace LE. ER\/LA opioid analgesics REMS: overview of ongoing assessments of its progress and its impact on health outcomes. Pain Med. 2017;18(1):78\u201385.","journal-title":"Pain Med"},{"key":"179_CR8","volume-title":"The President\u2019s commission on combating drug addiction and the opioid crisis","author":"C Christie","year":"2017","unstructured":"Christie C, Baker C, Cooper R, Kennedy PJ, Madras B, Bondi P. In: Office of National Drug Control Policy, editor. The President\u2019s commission on combating drug addiction and the opioid crisis. Washington, DC: The White House; 2017."},{"key":"179_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107\u201311.","journal-title":"Int J Drug Policy"},{"issue":"18","key":"179_CR10","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMc1505541","volume":"373","author":"TJ Cicero","year":"2015","unstructured":"Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373(18):1789\u201390.","journal-title":"N Engl J Med"},{"issue":"16","key":"179_CR11","first-page":"1573","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Severtson SG, Bucher-Bartelson B. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015a;372(16):1573\u20134.","journal-title":"N Engl J Med"},{"issue":"3","key":"179_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015b;372(3):241\u20138.","journal-title":"N Engl J Med"},{"key":"179_CR13","doi-asserted-by":"crossref","unstructured":"Dasgupta N, Beletsky L, Ciccarone D. Opioid Crisis: No Easy Fix to Its Social and Economic Determinants. American Journal of Public Health 2018;108(2):182\u201386.","DOI":"10.2105\/AJPH.2017.304187"},{"key":"179_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.drugalcdep.2015.02.010","volume":"150","author":"C Delcher","year":"2015","unstructured":"Delcher C, Wagenaar AC, Goldberger BA, Cook RL, Maldonado-Molina MM. Abrupt decline in oxycodone-caused mortality after implementation of Florida's prescription drug monitoring program. Drug Alcohol Depend. 2015;150:63\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"179_CR15","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","volume":"100","author":"J Emmanuelli","year":"2005","unstructured":"Emmanuelli J, Desenclos JC. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Addiction. 2005;100(11):1690\u2013700.","journal-title":"Addiction"},{"issue":"2","key":"179_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jsat.2004.06.005","volume":"27","author":"DA Fiellin","year":"2004","unstructured":"Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR. Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abus Treat. 2004;27(2):153\u20139.","journal-title":"J Subst Abus Treat"},{"issue":"12","key":"179_CR17","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","volume":"174","author":"DA Fiellin","year":"2014","unstructured":"Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O\u2019Connor PG. Primary care\u2013based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Intern Med. 2014;174(12):1947\u201354.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"179_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/15360288.2012.677946","volume":"26","author":"Food and Drug Administration","year":"2012","unstructured":"Food and Drug Administration. Shared risk evaluation mitigation strategy for all immediate-release Transmucosal fentanyl dosage forms. J Pain Palliat Care Pharmacother. 2012;26(2):123\u20136.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"1","key":"179_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08897077.2011.611460","volume":"33","author":"PD Friedmann","year":"2012","unstructured":"Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, et al. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abus. 2012;33(1):9\u201318.","journal-title":"Subst Abus"},{"issue":"Suppl 1","key":"179_CR20","first-page":"S135","volume":"117","author":"S Galea","year":"2002","unstructured":"Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117(Suppl 1):S135\u2013S45.","journal-title":"Public Health Rep"},{"issue":"41","key":"179_CR21","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.15585\/mmwr.mm6541a1","volume":"65","author":"MC Garcia","year":"2016","unstructured":"Garcia MC, Dodek AB, Kowalski T, Fallon J, Lee SH, Iademarco MF, et al. Declines in opioid prescribing after a private insurer policy change - Massachusetts, 2011-2015. MMWR Morb Mortal Wkly Rep. 2016;65(41):1125\u201331.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"179_CR22","volume-title":"Opiate Poisonings by Intent and County, 1999\u20132015","author":"Injury and Epidemiology Surveillance Unit, Injury and Violence Prevention Branch, Division of Pubilc Health, North Carolina Department of Health and Human Services","year":"2015","unstructured":"Injury and Epidemiology Surveillance Unit, Injury and Violence Prevention Branch, Division of Pubilc Health, North Carolina Department of Health and Human Services. Opiate Poisonings by Intent and County, 1999\u20132015. 2015."},{"issue":"1","key":"179_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2458-10-90","volume":"10","author":"MC Kegler","year":"2010","unstructured":"Kegler MC, Rigler J, Honeycutt S. How does community context influence coalitions in the formation stage? A multiple case study based on the community coalition action theory. BMC Public Health. 2010;10(1):90.","journal-title":"BMC Public Health"},{"issue":"3","key":"179_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/109019819802500308","volume":"25","author":"MC Kegler","year":"1998","unstructured":"Kegler MC, Steckler A, Mcleroy K, Malek SH. Factors that contribute to effective community health promotion coalitions: a study of 10 project ASSIST coalitions in North Carolina. Health Educ Behav. 1998;25(3):338\u201353.","journal-title":"Health Educ Behav"},{"issue":"4","key":"179_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.evalprogplan.2011.02.004","volume":"34","author":"HK Knudsen","year":"2011","unstructured":"Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann. 2011;34(4):375\u201381.","journal-title":"Eval Program Plann"},{"issue":"4","key":"179_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/ADM.0b013e3182312983","volume":"5","author":"ML Kraus","year":"2011","unstructured":"Kraus ML, Alford DP, Kotz MM, Levounis P, Mandell TW, Meyer M, et al. Statement of the American society of addiction medicine consensus panel on the use of buprenorphine in office-based treatment of opioid addiction. J Addict Med. 2011;5(4):254\u201363.","journal-title":"J Addict Med"},{"issue":"8","key":"179_CR27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/01.ajp.0000435447.96642.f4","volume":"30","author":"ET Lewis","year":"2014","unstructured":"Lewis ET, Cucciare MA, Trafton JA. What do patients do with unused opioid medications? Clin J Pain. 2014;30(8):654\u201362.","journal-title":"Clin J Pain"},{"key":"179_CR28","unstructured":"Lipari RN, Hughes A. How people obtain the prescription pain relievers they misuse. CBHSQ Report 2017(Jan 12):1\u20137."},{"key":"179_CR29","doi-asserted-by":"crossref","unstructured":"Mattick\u00a0\u00a0RP, Breen\u00a0\u00a0C, Kimber\u00a0\u00a0J, Davoli\u00a0\u00a0M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2). Art. No.: CD002207.","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"179_CR30","volume-title":"North Carolina's opioid action plan, 2017\u20132021","author":"North Carolina Department of Health and Human Services","year":"2017","unstructured":"North Carolina Department of Health and Human Services. North Carolina's opioid action plan, 2017\u20132021. 2017."},{"key":"179_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12963-015-0044-2","volume":"13","author":"PL Remington","year":"2015","unstructured":"Remington PL, Catlin BB, Gennuso KP. The county health rankings: rationale and methods. Popul Health Metrics. 2015;13:11.","journal-title":"Popul Health Metrics"},{"key":"179_CR32","doi-asserted-by":"crossref","unstructured":"Ringwalt C, Sanford C, Dasgupta N, Alexandridis A, McCort A, Proescholdbell S, et al. Community readiness to prevent opioid overdose. Health Promot Pract. 2018;19(5):747-55.","DOI":"10.1177\/1524839918756887"},{"key":"179_CR33","volume-title":"North Carolina vital statistics \u2014 deaths 2007-2014","author":"State Center for Health Statistics","year":"2015","unstructured":"State Center for Health Statistics. North Carolina vital statistics \u2014 deaths 2007-2014. V1 ed. Chapel Hill, NC: Odum Institute for Research in Social Science; 2015.","edition":"V1"},{"issue":"2","key":"179_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1176\/appi.ps.201300256","volume":"65","author":"CP Thomas","year":"2014","unstructured":"Thomas CP, Fullerton CA, Kim M, Montejano L, Lyman DR, Dougherty RH, et al. Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv. 2014;65(2):158\u201370.","journal-title":"Psychiatr Serv"},{"issue":"4","key":"179_CR35","first-page":"236","volume":"65","author":"CE Trado","year":"2004","unstructured":"Trado CE. Addressing pain management and palliative care: the official position of the North Carolina medical board. NC Med J. 2004;65(4):236\u201341.","journal-title":"NC Med J"},{"issue":"2","key":"179_CR36","doi-asserted-by":"publisher","first-page":"e54496","DOI":"10.1371\/journal.pone.0054496","volume":"8","author":"GJ Unick","year":"2013","unstructured":"Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS One. 2013;8(2):e54496.","journal-title":"PLoS One"},{"key":"179_CR37","volume-title":"National drug control strategy","author":"United States","year":"2015","unstructured":"United States. National drug control strategy. Washington, D.C.: Office of National Drug Control Policy, Executive Office of the President; 2015."},{"issue":"6","key":"179_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3109\/00952990.2015.1043435","volume":"41","author":"W Wakeland","year":"2015","unstructured":"Wakeland W, Nielsen A, Geissert P. Dynamic model of nonmedical opioid use trajectories and potential policy interventions. Am J Drug Alcohol Abuse. 2015;41(6):508\u201318.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"179_CR39","unstructured":"Web-based Injury Statistics Query and Reporting System (WISQARS) [online] [Internet]. 2005."}],"container-title":["Injury Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40621-018-0179-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40621-018-0179-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40621-018-0179-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T16:06:51Z","timestamp":1589558811000},"score":1,"resource":{"primary":{"URL":"https:\/\/injepijournal.biomedcentral.com\/articles\/10.1186\/s40621-018-0179-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,21]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1186\/s40621-018-0179-2","relation":{},"ISSN":["2197-1714"],"issn-type":[{"value":"2197-1714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,21]]},"assertion":[{"value":"25 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained through the Office of Human Reseach Ethics at the\u00a0University of North Carolina at Chapel Hill (IRB 12\u20132570, 17\u20130889).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"2"}}